Vive Organic Closes $13M Series B Funding Round


Vive Organic, a Venice, Calif.-based maker of doctor crafted, cold-pressed wellness shots, closed a $13m Series B funding.

The round was led by Monogram Capital with participation from Cambridge SPG and Powerplant Ventures.

The company intends to use the funds to expand its digital footprint, foster its innovation pipeline and make its plant-powered products more accessible to consumers nationwide.

Founded in 2015 by CEO Wyatt Taubman, COO Kyle Withycombe and VP of Sales JR Simich, Vive is a functional beverage brand providing customers with cold-pressed wellness shots that are formulated with a focus on boosting the immune system.

The company works with a team of holistic medicine doctors in its formulation to identify ingredients globally, with an emphasis on sourcing pure ginger, turmeric, elderberry and other immunity enhancing ingredients anywhere in the world. Vive leverages cold-pressed technology to extract juice from the roots, herbs and flowers used in their products to provide the freshest product with maximum health benefits.

The company’s beverages are organic, non-GMO, gluten free and vegan. Beginning with a focus on the natural channel, the company has expanded to meet rising demand from customers in 8,000 doors across natural, conventional, mass and drugstore accounts including key banners such as Whole Foods, Sprouts, Safeway, Wegman’s, Target, and CVS.



Join the discussion